Indo Rama Synthetics Q1 Results: Profit Rises YoY on Strong Margin Expansion

2 min read     Updated on 29 Jul 2026, 07:41 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Indo Rama Synthetics posted Q1 consolidated net profit of 637M rupees, up from 528M rupees YoY, despite revenue falling to 9.37B rupees from 13.1B rupees due to geopolitical headwinds. EBITDA rose sharply to 1.45B rupees from 970M rupees, with EBITDA margin expanding to 15.57% from 7.43%, underscoring strong margin-led performance. The Board also approved key leadership re-appointments and corporate governance updates ahead of the 40th AGM.

powered bylight_fuzz_icon
46878900

*this image is generated using AI for illustrative purposes only.

Indo Rama Synthetics reported a consolidated net profit of 637M rupees for Q1, marking a year-on-year increase from 528M rupees in the prior year quarter. Despite a decline in total revenue to 9.37B rupees from 13.1B rupees YoY, driven by volume impacts from West Asia geo-political issues, the company significantly expanded its EBITDA margin to 15.57% from 7.43% in the prior year quarter, reflecting improved product mix and resilient operational execution amid volatile market conditions.

The Board of Directors, meeting on July 29, 2026, approved the unaudited standalone and consolidated financial results as reviewed by statutory auditors SS Kothari Mehta & Co. LLP. In compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed these outcomes alongside corporate governance updates. The Board also amended the notice for the 40th Annual General Meeting, scheduled for September 8, 2026, due to changes in board composition.

Consolidated Financial Performance

The company's operational efficiency improved significantly despite lower top-line performance. EBITDA rose to 1.45B rupees from 970M rupees in the prior year quarter, reflecting strong cost management and a favourable product mix. Standalone net profit stood at ₹33.75 crore, up from ₹32.31 crore in the same period last year. Finance costs decreased slightly to ₹29.38 crore from ₹29.03 crore in the prior year quarter, while foreign exchange fluctuation losses remained contained at ₹2.91 crore.

The following table summarises the key consolidated financial metrics for the quarter:

Particulars: Q1FY27 Q1FY26
Total Revenue 9.37B Rupees 13.1B Rupees
EBITDA 1.45B Rupees 970M Rupees
EBITDA Margin (%) 15.57% 7.43%
Net Profit 637M Rupees 528M Rupees

Corporate Governance Updates

The Board re-constituted the Stakeholders Relationship Committee under Section 178 of the Companies Act, 2013, appointing Mr. Ravi Capoor as Chairman. Key committee members include Executive Directors Om Prakash Lohia and Vishal Lohia, Whole-time Director Sanjay Gupta, Non-executive Non-Independent Director Vipin Kumar, and Independent Director Atim Kabra.

Leadership Re-appointments

Subject to shareholder approval at the upcoming AGM, the Board approved the following re-appointments:

  • Om Prakash Lohia: Re-appointed as Chairman and Managing Director for three years, effective December 26, 2026, to December 25, 2029.
  • Dharmpal Agarwal: Re-appointed as Independent Director for five consecutive years, effective November 25, 2026, to November 24, 2031.

What the Numbers Show

The divergence between declining revenue and rising profitability highlights a margin-led performance strategy. While total revenue fell YoY due to external geopolitical headwinds affecting volumes, the EBITDA margin expanded substantially by over 800 basis points. This reflects Indo Rama's ability to mitigate cost pressures through product mix optimisation, enabling higher absolute profits despite a smaller sales base. The stability in finance costs further supported bottom-line resilience.

Historical Stock Returns for Indo Rama Synthetics

1 Day5 Days1 Month6 Months1 Year5 Years
+7.73%+6.84%+18.63%+19.45%+6.74%+1.70%

How might the ongoing geopolitical instability in West Asia impact Indo Rama Synthetics' export volumes and revenue recovery in Q2FY27?

Can the company sustain its expanded EBITDA margins of 15.57% if raw material costs rise or if the favorable product mix normalizes?

What specific operational strategies is management employing to offset the significant year-on-year revenue decline while maintaining profit growth?

Indo Rama Synthetics appoints Ambika Sharma, Atim Kabra as directors

2 min read     Updated on 28 Jul 2026, 10:07 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Indo Rama Synthetics has appointed Ambika Sharma and Atim Kabra as Non-Executive Independent Directors, effective July 27, 2026. The Board reconstituted key committees to integrate them, citing compliance with SEBI LODR Regulations and specific circulars. Shareholder approval is required at the ensuing AGM.

powered bylight_fuzz_icon
46720448

*this image is generated using AI for illustrative purposes only.

Indo Rama Synthetics (India) Limited indo rama synthetics appointed Ambika Sharma and Atim Kabra as Additional Directors on July 27, 2026, enhancing its governance framework with seasoned professionals in international business strategy and financial markets. The Board of Directors approved the appointments through resolutions passed by circulation, subject to final ratification by shareholders at the ensuing Annual General Meeting. Both appointees join as Non-Executive Independent Directors, serving five-year terms from July 27, 2026, to July 26, 2031, and are not liable to retire by rotation.

The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III. The company also cited compliance with SEBI circular SEBVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Both directors were recommended by the Nomination and Remuneration Committee and are confirmed as not debarred or disqualified by any order of the Ministry of Corporate Affairs or SEBI.

Ambika Sharma joins as a Non-Executive Independent Director (Woman). She brings extensive experience from her roles as Director General - International at FICCI and Managing Director of the U.S.-India Business Council. Atim Kabra joins as a Non-Executive Independent Director, leveraging his background as Executive Director at Astra Microwave Products Ltd and his expertise in equity research and portfolio management with global institutions like ABN AMRO Bank. Neither director is related to the promoters or existing board members.

Committee Reconstitutions

The Board reconstituted three key committees to integrate the new directors:

Audit Committee Pursuant to Section 177 of the Companies Act, 2013 and Regulation 18 of the Listing Regulations, the committee now includes:

Member Designation
Ravi Capoor Chairman
Dharmpal Agarwal Member
Neeru Abrol Member
Ambika Sharma Member
Vishal Lohia Member
Sanjay Gupta Member

Nomination and Remuneration Committee Under Section 178 of the Companies Act, 2013 and Regulation 19 of the Listing Regulations:

Member Designation
Dharmpal Agarwal Chairman
Ambika Sharma Member
Ravi Capoor Member
Vipin Jain Member

Stakeholders and Relationship Committee Governed by Section 178 of the Companies Act, 2013 and Regulation 20 of the Listing Regulations:

Member Designation
Ravi Capoor Chairman
Om Prakash Lohia Member
Vishal Lohia Member
Sanjay Gupta Member
Vipin Kumar Member

The disclosures were filed with the National Stock Exchange of India Limited and BSE Limited by Ashok Yadav, Company Secretary and Compliance Officer.

Historical Stock Returns for Indo Rama Synthetics

1 Day5 Days1 Month6 Months1 Year5 Years
+7.73%+6.84%+18.63%+19.45%+6.74%+1.70%

How might Ambika Sharma's expertise in U.S.-India business relations influence Indo Rama Synthetics' international expansion or export strategies?

What specific changes to the company's risk management or financial oversight protocols can be expected with Atim Kabra joining the Audit Committee?

Will the addition of these independent directors signal a potential shift in corporate governance priorities ahead of the upcoming Annual General Meeting?

More News on Indo Rama Synthetics

1 Year Returns:+6.74%